Brainsway
Yahoo Finance • last month
Brainsway stock maintains Buy rating at H.C. Wainwright after strategic investments
Investing.com - H.C. Wainwright has reiterated a Buy rating and $17.00 price target on Brainsway (NASDAQ:BWAY), the $288 million market cap medical device company that has delivered an impressive 61% return year-to-date. According to Inves... Full story
Yahoo Finance • last month
BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd.
This investment marks BrainsWay’s entrance into the market for mental health therapies that can be administered outside of a clinic, including at home Neurolief’s breakthrough Proliv™Rx device is pending Premarket Approval from the U.S. F... Full story
Yahoo Finance • last month
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • last month
BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights
Achieved record quarterly revenue of $12.6 million in Q2 2025, an increase of 26% compared to Q2 2024 Operating profit totaled $0.6 million and Adjusted EBITDA rose to $1.5 million, Raised full-year 2025 Revenue and EBITDA guidance Rema... Full story
Yahoo Finance • last month
S&P Futures Gain as Fed Rate-Cut Bets Firm
September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning, extending yesterday’s gains as growing expectations for Federal Reserve interest rate cuts fueled risk-on sentime... Full story
Yahoo Finance • last month
Here are the major earnings before the open Wednesday
Major earnings expected before the bell on Wednesday include: * Tencent Holdings Limited (OTCPK:TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Stratasys Ltd. (SSYS [https://seekingalpha.com/symbol/SSYS]) * Organigram Global (OGI [... Full story
Yahoo Finance • 2 years ago
Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction
BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, anno... Full story
Yahoo Finance • 2 years ago
BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023
BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 2 years ago
BrainsWay Announces Presentation of Two Deep TMS™ Posters at Upcoming World Congress of Psychiatry
BURLINGTON, Mass. and JERUSALEM, Sept. 27, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, tod... Full story
Yahoo Finance • 2 years ago
BrainsWay Announces Significant Expansion in Western and Central U.S.
BURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 2 years ago
BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
BrainsWay BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported fir... Full story
Yahoo Finance • 2 years ago
BrainsWay Launches Investigator Initiated Study (IIS) Program
BURLINGTON, Mass. and JERUSALEM, May 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today... Full story
Yahoo Finance • 2 years ago
BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS™ in Treating Depression and Anxious Depression
Real-World Evidence Demonstrates the Highest Response and Remission Rates Observed to Date for Deep BURLINGTON, Mass. and JERUSALEM, March 28, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”),... Full story
Yahoo Finance • 3 years ago
BrainsWay Announces Appointment of Hadar Levy as CEO
BrainsWay BURLINGTON, Mass. and JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disord... Full story
Yahoo Finance • 3 years ago
BrainsWay Announces Appointment of Ami Boehm as New Chairman
BrainsWay David Zacut, M.D., Relinquishing Chairman Role Held Since Company’s Inception, to Now Serve as Board Director BURLINGTON, Mass. and JERUSALEM, Feb. 13, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”... Full story
Yahoo Finance • 3 years ago
BrainsWay Announces Extended Private Insurance Coverage in Washington State for the Treatment of OCD and Depression Utilizing Deep TMS™
BrainsWay BURLINGTON, Mass. and JERUSALEM, Jan. 11, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disord... Full story
Yahoo Finance • 3 years ago
BrainsWay Announces Private Insurance Coverage from Premera Blue Cross for the Treatment of OCD Utilizing Deep TMS™
BURLINGTON, Mass. and JERUSALEM, Nov. 03, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 3 years ago
BrainsWay to Report Third Quarter Financial Results on November 16, 2022
BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 3 years ago
BrainsWay Appoints Dr. Colleen A. Hanlon as Vice President of Medical Affairs
BURLINGTON, Mass. and JERUSALEM, Nov. 01, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, toda... Full story
Yahoo Finance • 3 years ago
BrainsWay Launches Social Media Sweepstakes in Observance of Depression Awareness Month
BURLINGTON, Mass. and JERUSALEM, Oct. 12, 2022 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the launch... Full story
